These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 417373)

  • 21. Involvement of cholinergic nicotine-like receptors as modulators of amine turnover in various types of hypothalamic dopamine and noradrenaline nerve terminal systems and of prolactin, LH, FSH and TSH secretion in the castrated male rat.
    Andersson K; Fuxe K; Eneroth P; Agnati LF
    Acta Physiol Scand; 1982 Sep; 116(1):41-50. PubMed ID: 6818838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthyroidism: specifically increased response to central NA-(alpha-)receptor stimulation and generally increased monoamine turnover in brain.
    Strömbom U; Svensson TH; Jackson DM; Engström G
    J Neural Transm; 1977; 41(1):73-92. PubMed ID: 915501
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropeptide Y alters monoamine turnover in the rat brain.
    Vallejo M; Carter DA; Biswas S; Lightman SL
    Neurosci Lett; 1987 Jan; 73(2):155-60. PubMed ID: 3822247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurochemical and neurophysiological mechanisms of the psychostimulant action of phenamine].
    Arushanian EB
    Farmakol Toksikol; 1975; 38(1):111-20. PubMed ID: 163205
    [No Abstract]   [Full Text] [Related]  

  • 26. The role if dopamine and norepinephrine uptake inhibition in mediating the central effects of d-amphetamine in vivo.
    Feigenbaum JJ; Yanai J; Blass RB
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):333-5. PubMed ID: 7071417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 28. Catecholamine alterations in experimental hydrocephalus.
    Miyake H; Eghwrudjakpor PO; Sakamoto T; Mori K
    Childs Nerv Syst; 1992 Aug; 8(5):243-6. PubMed ID: 1394262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estradiol-17 beta and other steroids on noradrenaline and dopamine binding to synaptic membrane fragments of rat brain.
    Inaba M; Kamata K
    J Steroid Biochem; 1979 Oct; 11(4):1491-7. PubMed ID: 513767
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
    Monti JM
    Br J Pharmacol; 1979 Sep; 67(1):87-91. PubMed ID: 40644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of social isolation on brain catecholamines and forced swimming in rats: prevention by antidepressant treatment.
    Heritch AJ; Henderson K; Westfall TC
    J Psychiatr Res; 1990; 24(3):251-8. PubMed ID: 2266513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caffeine down-regulates beta adrenoreceptors in rat forebrain.
    Goldberg MR; Curatolo PW; Tung CS; Robertson D
    Neurosci Lett; 1982 Jul; 31(1):47-52. PubMed ID: 6289200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.
    Lassen JB
    Psychopharmacologia; 1974; 37(4):331-40. PubMed ID: 4136728
    [No Abstract]   [Full Text] [Related]  

  • 35. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
    Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unstimulated and amphetamine-stimulated release of endogenous noradrenaline and dopamine from rat brain in vivo.
    Philips SR; Robson AM; Boulton AA
    J Neurochem; 1982 Apr; 38(4):1106-10. PubMed ID: 7062033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome.
    Heidbreder CA; Weiss IC; Domeney AM; Pryce C; Homberg J; Hedou G; Feldon J; Moran MC; Nelson P
    Neuroscience; 2000; 100(4):749-68. PubMed ID: 11036209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive avoidance performance correlates with catecholamine turnover in discrete limbic brain regions.
    Kovács GL; Versteeg DH; de Kloet ER; Bohus B
    Life Sci; 1981 Mar; 28(10):1109-16. PubMed ID: 6112649
    [No Abstract]   [Full Text] [Related]  

  • 39. The identification of specific brain nuclei in which catecholamine turnover is increased by left ventricular receptors during acute myocardial infarction in the rat.
    Sole MJ; Hussain MN; Versteeg DH; de Kloet ER; Adams D; Lixfeld W
    Brain Res; 1982 Mar; 235(2):315-25. PubMed ID: 7188330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.